Current Report Filing (8-k)
17 Janeiro 2023 - 5:56PM
Edgar (US Regulatory)
0000912544
false
0000912544
2023-01-13
2023-01-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
DATE
OF REPORT (DATE OF EARLIEST EVENT REPORTED):
January
13, 2023
NOVELSTEM
INTERNATIONAL CORP.
(EXACT
NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
florida
(STATE
OR OTHER JURISDICTION OF INCORPORATION)
| 001-14332 |
|
65-0385686 |
| (COMMISSION
FILE NUMBER) |
|
(I.R.S.
EMPLOYER IDENTIFICATION NO.) |
2255
Glades Road, Ste. 221A
Boca
Raton, FL 33431
(ADDRESS
OF PRINCIPAL EXECUTIVE OFFICES)
(410)
654-3315
(REGISTRANT’S
TELEPHONE NUMBER, INCLUDING AREA CODE)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Exchange Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| None |
|
None |
|
None |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02. Departure of Directors or certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
On
January 13, 2023, the Board of Directors of Novelstem International Corp. (the “Company”) appointed Mr. Jan Loeb as President
and Ms. Christine Jenkins as Vice President of the Company. Mr. Loeb has served as Chairman of the Company’s Board of Directors
since July 2018 and as Executive Chairman since September 2022. Ms. Jenkins has served as the Company’s Chief Financial Officer
and Secretary since September 2022.
There
are no arrangements or understandings with Mr. Loeb or Ms. Jenkins and any other person pursuant to which he or she was appointed to
their respective
positions. There are no family relationships between either Mr. Loeb or Ms. Jenkins and any director or executive officer of the Company,
and, except as disclose herein, neither Mr. Loeb nor Ms. Jenkins is a party to a related party transaction within the meaning of Item
404(a) of Regulation S-K.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
| 104 |
Cover
Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
NOVELSTEM
INTERNATIONAL CORP. |
| |
|
|
| Date:
January 17, 2023 |
By:
|
/s/
Jan Loeb |
| |
|
Jan
Loeb |
| |
|
President |
NovelStem (PK) (USOTC:NSTM)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
NovelStem (PK) (USOTC:NSTM)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
